NCT02055092

Brief Summary

People diagnosed with young onset dementia are today mostly assigned to the same healthcare services as people developing dementia at an older age. They and their families are however in a quite different life situation, which is likely to generate different challenges and specific needs for tailored healthcare services, of importance in maintaining their perceived quality of life. The investigators of this study wish to assess the factors influencing these families' quality of life, their specific needs and their use of healthcare services by the use a combination of quantitative and qualitative methods. The main aim of this study is to provide better future healthcare services to these families, and to develop a programme for optimal collaboration between specialist healthcare services and the local dementia teams.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
250

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Feb 2014

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 31, 2014

Completed
1 day until next milestone

Study Start

First participant enrolled

February 1, 2014

Completed
3 days until next milestone

First Posted

Study publicly available on registry

February 4, 2014

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2017

Completed
3.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2020

Completed
Last Updated

March 8, 2021

Status Verified

March 1, 2021

Enrollment Period

3.3 years

First QC Date

January 31, 2014

Last Update Submit

March 5, 2021

Conditions

Keywords

Young onset dementiaQuality of lifeSpecific needsHealthcare resources in dementiaFrontotemporal dementiaAlzheimer's diseaseHealthcare services

Outcome Measures

Primary Outcomes (3)

  • Quality of life

    Assessments by Quality of Life - Alzheimer's dementia (QoL-AD) and Euroqol-5D (EQ-5D), index person and family member; also by proxy (QoL-AD).

    Baseline

  • Change from baseline in quality of life at 12 months

    Assessments by Quality of Life - Alzheimer's dementia (QoL-AD) and Euroqol-5D (EQ-5D), index person and family member; also by proxy (QoL-AD).

    Baseline, 12 months

  • Change from baseline in quality of life at 24 months

    Assessments by Quality of Life - Alzheimer's dementia (QoL-AD) and Euroqol-5D (EQ-5D), index person and family member; also by proxy (QoL-AD).

    Baseline, 24 months

Secondary Outcomes (18)

  • Specific needs

    Baseline

  • Use of healthcare resources

    Baseline

  • Cognition

    Baseline

  • Neuropsychiatric symptoms

    Baseline

  • Activities of Daily Living (ADL)

    Baseline

  • +13 more secondary outcomes

Other Outcomes (26)

  • Clinical dementia rating

    Baseline

  • Awareness

    Baseline

  • Depressive symptoms

    Baseline

  • +23 more other outcomes

Study Arms (3)

YOD-FTD

Young onset dementia - frontotemporal dementia, 38 persons with their respective family members.

YOD-AD

Young onset dementia - Alzheimer's disease, 50 persons with their respective family members.

LOD

Late onset dementia \>= 70 years of age; Control group of 100 persons with dementia (mostly AD and AD/vascular) and their respective family members. Data already collected in a previous study.

Eligibility Criteria

AgeUp to 69 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

YOD participants are community residing persons recruited from memory clinics in Norway and Nordic countries (Iceland, Sweden and Denmark).

You may qualify if:

  • FTD (Neary et al 1998 criteria)
  • Primary progressive aphasia (Mesulam 2003 criteria)
  • AD (DSM-IV)
  • Community living, excl. dementia-specific living facilities manned 24/7
  • Family member with regular contact at least x 1/week.

You may not qualify if:

  • Lack of informed consent
  • No close or appropriate family member
  • Frontal lobe dysfunction due to non-progressive injury, i.e. cerebral infarction
  • Frontal lobe dysfunction due to motor neuron disease (ALS)
  • Other dementia specific condition with frontal lobe dysfunction (Huntington, HIV, Down syndrome, alcoholic dementia)
  • Mental retardation
  • Current substance abuse, incl. excessive alcohol consumption for the past 12 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Norwegian Centre for Ageing and Health

Tønsberg, Vestfold, 3103, Norway

Location

Related Publications (1)

  • Hvidsten L, Engedal K, Selbaek G, Wyller TB, Saltyte Benth J, Bruvik F, Kersten H. Quality of life of family carers of persons with young-onset compared to late-onset dementia. Aging Ment Health. 2020 Sep;24(9):1394-1401. doi: 10.1080/13607863.2019.1617245. Epub 2019 May 20.

Biospecimen

Retention: SAMPLES WITH DNA

Bio samples are collected for analysis and storage in a bio bank as part of the routines for the National Registry of Dementia: * Blood plasma and serum for the later analysis of inflammation markers. * Whole blood for analysis of apolipoprotein E4-genotype. * Cerebrospinal fluid for dementia markers (tau-protein, amyloid). * Saliva cortisol.

MeSH Terms

Conditions

Frontotemporal DementiaAlzheimer Disease

Condition Hierarchy (Ancestors)

Frontotemporal Lobar DegenerationDementiaBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesTDP-43 ProteinopathiesNeurodegenerative DiseasesProteostasis DeficienciesMetabolic DiseasesNutritional and Metabolic DiseasesNeurocognitive DisordersMental DisordersTauopathies

Study Officials

  • Geir Selbæk, MD, PhD

    Norwegian Centre for Ageing and Health

    STUDY DIRECTOR
  • Hege Kersten, CPh, PhD

    Norwegian Centre for Ageing and Health

    STUDY CHAIR
  • Aud Johannessen, DrPH

    Norwegian Centre for Ageing and Health

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 31, 2014

First Posted

February 4, 2014

Study Start

February 1, 2014

Primary Completion

June 1, 2017

Study Completion

July 1, 2020

Last Updated

March 8, 2021

Record last verified: 2021-03

Locations